Company news

Spectral Medical Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Spectral announces third quarter 2010 results

November 15, 2010

Spectral initiates U.S. pivotal trial of Toraymyxin¿ in septic shock

October 19, 2010

Spectral to present at rodman & renshaw annual global investment conference on September 13

September 13, 2010

Spectral announces second quarter 2010 results

August 12, 2010

Spectral receives McMaster Industry Partner of the Year Award for aptamer discovery research

June 23, 2010

Spectral announces first quarter financial results

May 14, 2010

Spectral announces presentations at the 8th Annual World Congress on Trauma, Shock, Inflammation and Sepsis focusing on the role of endotoxin

March 12, 2010

Spectral announces 2009 financial results

March 11, 2010

Spectral appoints two new board members

March 10, 2010

Spectral closes $19.5 million private placement financing

March 3, 2010

Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM)

March 2, 2010

Spectral shareholders approve $19.5 million private placement financing

February 26, 2010

Spectral increases private placement financing to $19.5 million

February 3, 2010

Spectral announces third quarter 2009 results

November 12, 2009

Spectral appoints new board member

August 13, 2009

Spectral announces second quarter 2009 results

August 13, 2009

Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial

June 18, 2009

Spectral announces first quarter 2009 results

May 14, 2009

Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin

March 25, 2009

Spectral announces 2008 financial results

March 12, 2009

Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market

March 9, 2009

Spectral presents data on the clinical utility of EAA(TM) at 13th Annual Critical Care for Endotoxemia conference in Japan

February 23, 2009

Spectral announces third quarter 2008 results

November 12, 2008

Spectral to bring anti-sepsis therapy to the U.S. market

September 23, 2008

Spectral announces second quarter 2008 results

August 13, 2008

Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay

July 10, 2008

Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics

June 26, 2008

Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination

June 2, 2008

Spectral announces first quarter 2008 results

May 14, 2008

Spectral and Toray expand collaboration to include new geographic territories

May 5, 2008

Spectral's EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy

April 9, 2008

Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine

March 18, 2008

Spectral announces 2007 financial results

March 7, 2008

Spectral appoints Anthony Bihl to Board of Directors

March 6, 2008

Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan

February 28, 2008

Spectral announces license agreement with Bio-Rad Pasteur S.A.

November 19, 2007

Spectral announces third quarter fiscal 2007 financial results

November 8, 2007

Spectral and Toray expand distribution of EAA(TM) diagnostic in Japan

November 6, 2007

Spectral Co-hosts Endotoxemia Scientific Session at SEPSIS 2007

September 27, 2007

Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany

September 20, 2007

Spectral reports second quarter results

August 9, 2007

Spectral launches U.S. distribution of its Rapid West Nile Test

July 4, 2007

Spectral's EAA(TM) Proven Effective in Veterinary Applications

June 6, 2007

Spectral and Menarini sign European EAA(TM) distribution agreement

May 22, 2007

Spectral and Estor strengthen EAA(TM) market position in Italy

May 16, 2007

Spectral reports first quarter results

May 9, 2007

Spectral's RapidWN West Nile Virus IgM Test presented at Oak Ridge Conference

April 19, 2007

Spectral's EAA(TM) to be featured at The International Symposium of Intensive Care and Emergency Medicine

March 26, 2007

Spectral Announces Significant EAA(TM) Presentations at 7th World TSIS Congress

March 13, 2007

Spectral Announces Financial Results

March 8, 2007

← Newer news releases · Older news releases →

Calls

Decks